MedPath
NMPA Approval

Perampanel Oral Suspension

国药准字HJ20230052

May 12, 2023

Drug Information

吡仑帕奈口服混悬液

口服混悬剂

340ml:170mg

化学药品

May 12, 2023

May 11, 2028

Company Information

Applicant Company

European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire, AL10 9SN, United Kingdom

Manufacturing Company

26 rue de la Chapelle, Huningue, F-68330, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

吡仑帕奈口服混悬液 - NMPA 批准文号 | MedPath